![]() SpringWorks Therapeutics SpringWorks Therapeutics is dedicated to developing innovative potential new treatments for unserved and underserved patient communities. | ![]() Repare Therapeutics Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells. | ||||
Founding Date | Founding Date 2017 | Founding Date 2016 | Founding Date 1856 | Founding Date 1989 | Founding Date 1919 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Stamford, US HQ Durham, US | Locations Montréal, CA HQ Cambridge, US | Locations Watford, GB HQ Buenos Aires, AR Macquarie Park, AU Schwechat, AT Zaventem, BE São Paolo, BR Mississauga, CA see more | Locations Innsbruck, AT HQ | Locations Duderstadt, DE HQ Ouled Fayet, DZ Buenos Aires, AR Baulkham Hills, AU Wien, AT Sarajevo, BA see more |
Employees | Employees 568% increase | Employees 129 | Employees 17,349 | Employees 1,9611% increase | Employees 3,893 |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 152.4 m | Valuation ($) 13.4 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $191.6m (FY, 2024) | Revenue (est.) $53.5m (FY, 2024) | Revenue (est.) $6.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $12.6m (FY, 2024) | Cost of goods N/A | Cost of goods $1.4b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $179m (FY, 2024) | Gross profit $53.5m (FY, 2024) | Gross profit $4.8b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($258.1m) (FY, 2024) | Net income ($84.7m) (FY, 2024) | Net income $625m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 228m | Total funding raised $ 150.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |

Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
View company
Smith & Nephew is a medical technology company.
View companyMED-EL is a company providing hearing loss solutions.
View company
Otto Bock HealthCare is a med tech company.
View company